NO870031L - Fremgangsmaate for fremstilling av antibakerielle monosulflaktamer. - Google Patents

Fremgangsmaate for fremstilling av antibakerielle monosulflaktamer.

Info

Publication number
NO870031L
NO870031L NO870031A NO870031A NO870031L NO 870031 L NO870031 L NO 870031L NO 870031 A NO870031 A NO 870031A NO 870031 A NO870031 A NO 870031A NO 870031 L NO870031 L NO 870031L
Authority
NO
Norway
Prior art keywords
sub
antibacterial
monosulflactames
procedure
preparation
Prior art date
Application number
NO870031A
Other languages
English (en)
Other versions
NO870031D0 (no
NO166860B (no
NO166860C (no
Inventor
Joseph Edward Sundeen
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of NO870031D0 publication Critical patent/NO870031D0/no
Publication of NO870031L publication Critical patent/NO870031L/no
Priority to NO905385A priority Critical patent/NO905385D0/no
Publication of NO166860B publication Critical patent/NO166860B/no
Publication of NO166860C publication Critical patent/NO166860C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
NO870031A 1986-01-06 1987-01-05 Analogifremgangsmaate for fremstilling av terapeutisk aktive monosulfaktamer. NO166860C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO905385A NO905385D0 (no) 1986-01-06 1990-12-13 Tiazolderivater egnet som mellomprodukter ved fremstilling av terapeutisk aktive monosulfaktamer.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/816,475 US4684722A (en) 1986-01-06 1986-01-06 Monosulfactams

Publications (4)

Publication Number Publication Date
NO870031D0 NO870031D0 (no) 1987-01-05
NO870031L true NO870031L (no) 1987-07-07
NO166860B NO166860B (no) 1991-06-03
NO166860C NO166860C (no) 1991-09-11

Family

ID=25220721

Family Applications (1)

Application Number Title Priority Date Filing Date
NO870031A NO166860C (no) 1986-01-06 1987-01-05 Analogifremgangsmaate for fremstilling av terapeutisk aktive monosulfaktamer.

Country Status (21)

Country Link
US (1) US4684722A (no)
EP (1) EP0229012B1 (no)
JP (1) JPS62158278A (no)
KR (1) KR900002244B1 (no)
AT (1) ATE64393T1 (no)
AU (3) AU602133B2 (no)
CA (1) CA1308107C (no)
DD (3) DD256700A5 (no)
DE (1) DE3770644D1 (no)
DK (1) DK3087A (no)
ES (1) ES2038127T3 (no)
FI (1) FI870030A (no)
GR (1) GR3002312T3 (no)
HU (2) HU198700B (no)
IL (1) IL81153A (no)
NO (1) NO166860C (no)
NZ (1) NZ218682A (no)
PH (1) PH23052A (no)
SU (1) SU1517762A3 (no)
YU (2) YU227886A (no)
ZA (1) ZA8771B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6452767A (en) * 1986-03-19 1989-02-28 Banyu Pharma Co Ltd 2-(2-aminothiazol-4-yl)-2-(1-carboxy-1-vinyloxyimino)acetic acid derivative and production thereof
JPS6393796A (ja) * 1986-10-09 1988-04-25 Shin Etsu Chem Co Ltd ペプチド合成の脱保護基用薬剤
US5143913A (en) * 1988-04-04 1992-09-01 E. R. Squibb & Sons, Inc. [3S(Z)]-3-[[(2-amino-4-thiazolyl)[[2-(hydroxyamino)-2-oxoethoxy]imino]acetyl]amino]-2,2-dimethyl-4-oxo-1-azetidinyl sulfate
JPH07165740A (ja) * 1994-11-07 1995-06-27 Banyu Pharmaceut Co Ltd ２−（２−アミノチアゾリル）−２−（１−カルボキシ−１−ビニルオキシイミノ）酢酸及びその製法
US5952306A (en) * 1996-01-16 1999-09-14 Merck & Co., Inc. Integrin receptor antagonists
CA2242877A1 (en) * 1996-01-16 1997-07-24 Merck & Co., Inc. Integrin receptor antagonists
US9120796B2 (en) 2013-10-02 2015-09-01 Cubist Pharmaceuticals, Inc. B-lactamase inhibitor picoline salt
JP7184646B2 (ja) 2015-12-15 2022-12-06 メルク・シャープ・アンド・ドーム・エルエルシー ビアリールモノバクタム化合物および細菌感染治療のためのそれの使用方法
KR102408800B1 (ko) 2016-03-07 2022-06-13 머크 샤프 앤드 돔 코포레이션 비시클릭 아릴 모노박탐 화합물 및 박테리아 감염의 치료를 위한 그의 사용 방법
US10002721B1 (en) * 2017-02-27 2018-06-19 Carling Technologies, Inc. Multiple contact circuit breaker
MA50629A (fr) 2017-10-02 2021-03-31 Merck Sharp & Dohme Composés monobactames de chromane pour le traitement d'infections bactériennes
CN113754651B (zh) * 2020-06-02 2023-04-18 中国医学科学院医药生物技术研究所 一种β-内酰胺化合物、其用途及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU526540B2 (en) * 1976-04-12 1983-01-20 Fujisawa Pharmaceutical Co., Ltd. Oximes of substituted phenyl, thiazolyl - glyoxylic acids
DE2716677C2 (de) * 1977-04-15 1985-10-10 Hoechst Ag, 6230 Frankfurt Cephemderivate und Verfahren zu ihrer Herstellung
GB1602725A (en) * 1977-04-27 1981-11-18 Glaxo Operations Ltd 7-(a-oxyiminoacetamido)-ceph-3-em-4-carboxylic acid derivatives
US4409214A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical, Co., Ltd. 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
US4533660A (en) * 1980-10-31 1985-08-06 E. R. Squibb & Sons, Inc. Antibacterial O-sulfated β-lactam hydroxamic acids
JPS58113174A (ja) * 1981-12-26 1983-07-05 Toyama Chem Co Ltd 新規なアゼチジン誘導体またはその塩類を含有する抗菌剤
US4443374A (en) * 1982-02-01 1984-04-17 E. R. Squibb & Sons, Inc. Process for preparing (3S)-3-[[(2-amino-4-thiazolyl)[(1-carboxy-1-methylethoxy)imino]-acetyl]amino]-2-oxo-1-azetidinesulfonic acid, and 4-substituted derivatives
AU564150B2 (en) * 1982-04-30 1987-08-06 Takeda Chemical Industries Ltd. 1-sulfo-2-azetidinone derivatives
JPS58206589A (ja) * 1982-05-26 1983-12-01 Yamanouchi Pharmaceut Co Ltd ２−アゼチジノン誘導体
JPS58210060A (ja) * 1982-05-31 1983-12-07 Takeda Chem Ind Ltd ２−オキソアゼチジン誘導体、その製造法および用途
HU189290B (en) * 1982-05-31 1986-06-30 Banyu Pharmaceutical Co Ltd,Jp Process for preparing new 2-oxo-1-azetidine-sulphonic acid derivatives and pharmaceutically acceptable salts thereof, further pharmaceutical compositions containing such derivatives as active substances
EP0096296B1 (de) * 1982-06-03 1987-07-29 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft 1-Sulfo-2-oxoazetidinderivate
EP0096297B1 (de) * 1982-06-03 1988-06-15 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Verfahren zur Herstellung von 1-Sulfo-2-oxoazetidinderivaten
US4704457A (en) * 1982-06-21 1987-11-03 E. R. Squibb & Sons, Inc. Process for the preparation of (3S)-3-[[[2-(protected amino)-4-thiazolyl]-oxoacetyl]amino]-2-oxo-1-azetidinesulfonic acid and 4-substituted derivatives thereof
GB8413152D0 (en) * 1983-06-03 1984-06-27 Ici Pharma Cephalosporin derivatives
DE3342929A1 (de) * 1983-11-26 1985-06-05 Bayer Ag, 5090 Leverkusen Ss-lactamantibiotika, verfahren zu deren herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
ZA8771B (en) 1987-08-26
NO870031D0 (no) 1987-01-05
HUT48876A (en) 1989-07-28
HU198926B (en) 1989-12-28
KR900002244B1 (ko) 1990-04-07
AU617059B2 (en) 1991-11-14
DE3770644D1 (de) 1991-07-18
PH23052A (en) 1989-03-10
AU602133B2 (en) 1990-10-04
FI870030A (fi) 1987-07-07
HUT44540A (en) 1988-03-28
IL81153A0 (en) 1987-08-31
AU6680886A (en) 1987-07-09
KR870007164A (ko) 1987-08-17
EP0229012B1 (en) 1991-06-12
ES2038127T3 (es) 1993-07-16
DD267039A5 (de) 1989-04-19
DD267035A5 (de) 1989-04-19
DD256700A5 (de) 1988-05-18
HU198700B (en) 1989-11-28
IL81153A (en) 1991-06-10
DK3087A (da) 1987-07-07
FI870030A0 (fi) 1987-01-05
JPS62158278A (ja) 1987-07-14
NO166860B (no) 1991-06-03
EP0229012A1 (en) 1987-07-15
US4684722A (en) 1987-08-04
GR3002312T3 (en) 1992-12-30
AU5885190A (en) 1990-10-25
AU5885090A (en) 1990-11-15
NZ218682A (en) 1990-05-28
CA1308107C (en) 1992-09-29
NO166860C (no) 1991-09-11
YU127887A (en) 1988-04-30
SU1517762A3 (ru) 1989-10-23
DK3087D0 (da) 1987-01-05
YU227886A (en) 1988-02-29
ATE64393T1 (de) 1991-06-15

Similar Documents

Publication Publication Date Title
AU5428486A (en) Phenyl carbamates
NO870031L (no) Fremgangsmaate for fremstilling av antibakerielle monosulflaktamer.
EG17752A (en) Benzoylurea derivatives
ES8800910A1 (es) Un procedimiento para la preparacion de nuevas quinazolindionas
CA1270247C (en) 3-ACYLAMINO-2-OXO-1-AZETIDINESULFONIC ACIDS
GR3007423T3 (no)
GB2005247A (en) Perhydro naphthalene derivatives
FR2608169B1 (fr) Module de culture de micro-organismes
CA1271750C (en) 3-ACYLAMINO-2-OXO-1-AZETIDINESULFONIC ACIDS
FI841240A0 (fi) Foerbaettringar i makrolidantibiotika.
SU1271155A1 (ru) Способ создания лазерноактивных центров окраски tl°va*99+ в кристаллах kcl-tl
SU1203863A1 (ru) 6-циклогексил-2-окса-6-азаспиро (3,3) гептан, подавляющий рост сульфатвосстанавливающих бактерий
IT214763Z2 (it) Struttura per l'aerazione di scantinati.
AU1173388A (en) Use of hydroxylated indoles as dye precursors